-
News | 2019.07.12
Wolbachia, bacteria to combat dengue
The first mosquitoes carrying Wolbachia, bacteria that prevent them from transmitting arboviruses (including dengue, Zika and chikungunya), were released on Wednesday July 10, 2019 in Nouméa, New Caledonia, as part of the World Mosquito Program,* which involves teams from the Institut Pasteur de Nouvelle-Calédonie. The aim of this program is to encourage mosquitoes infected with Wolbachia to...
-
News | 2021.05.03
New Edition of the Emerging & Re-emerging Viruses MOOC
Free et Self-pacedEmerging and re-emerging viruses are key players among the different pathogens that have caused recent epidemics, as attested by several severe outbreaks affecting humans such as Ebola, chikungunya, influenza, Zika, dengue, SARS and MERS or outbreaks attacking animals such as rabies and bluetongue disease.This MOOC aims to provide a fundamental knowledge about the different...
-
News | 2022.02.28
Signing of an exclusive license agreement between the Institut Pasteur and Meletios Therapeutics for the development of a new class of antivirals
The exclusive worldwide license agreement signed between the Institut Pasteur and Meletios Therapeutics, a French biotechnology company specializing in the research and development of next-generation antiviral therapies, concerned a technology platform for the generation of Defective Viral Genomes (DVG). DVGs are truncated or rearranged copies of a virus, making these viral sequences non-...
-
News | 2023.06.06
Tiger mosquito: two viruses newly transmitted from birds to humans
Scientists from the Institut Pasteur have demonstrated that the tiger mosquito, already a vector of diseases such as dengue and chikungunya, has become capable of transmitting the West Nile and Usutu viruses. This emergence may be surprising, but steps can already be taken to tackle it.
-
News | 2022.03.22
Ukrainian scientists: offer to join a host laboratory at the Institut Pasteur in Paris
In view of the ongoing war in Ukraine, the Institut Pasteur is providing funding to host Ukrainian scientists in its research laboratories.
-
Document de presse | 2017.02.27
Infravec2 project launch: A European Commission 10M€ effort to fight mosquito-transmitted diseases
On February 14, the European Commission officially approved the Infravec2 project . This project will improve the European large-scale facilities (infrastructures) for research on mosquitoes and other insects (vectors) that carry human and animal diseases, and will promote sharing of the facilities by European researchers. The Infravec2 project is funded by the Commission’s Horizon 2020...
-
Document de presse | 2017.11.03
Rift Valley fever virus: an infection mechanism identified
Rift Valley fever virus, transmitted by mosquitoes, is responsible for outbreaks in livestock in Africa and can also be fatal in humans. Scientists from the Institut Pasteur and the CNRS, working with the University of Göttingen, have characterized the mechanism used by the virus to insert one of its envelope proteins into the host cell membrane, thereby enabling it to infect the cell. They have...
-
News | 2018.05.22
Tiger mosquitoes: heightened surveillance in France, from May to November 2018
On Monday April 30, 2018, the French Ministry of Health announced that it was stepping up surveillance of the tiger mosquito, Aedes albopictus, which is now present in 42 French départements – twice as many as two years ago. But just how dangerous is this mosquito, vector of diseases such as dengue, chikungunya or zika?The tiger mosquito (see What is the "tiger mosquito" (Aedes albopictus)?) is...
-
News | 2020.02.27
Foreign travel – a tonic for the health?
All travelers can come into contact with health risks that are completely different from those they generally encounter on a daily basis. So it is vital to prepare thoroughly for any trip – and that involves consulting a specialist travel clinic such as the Institut Pasteur Medical Center (CMIP).Travel is a formative experience for young people – and young people often take a casual attitude to...
-
Article | 2019.06.25
Host-pathogen interactions (33 entities)
Pathogens have evolved sophisticated strategies to infect, propagate and persist within their hosts. Here, host-pathogen interactions are studied at the molecular, cellular, organ and whole-organism levels. The long-term goal of these studies is to identify novel targets for diagnosis, vaccination and treatment.
